Detalhe da pesquisa
1.
Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome.
Cell
; 186(13): 2839-2852.e21, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352836
2.
Design, construction, and in vivo augmentation of a complex gut microbiome.
Cell
; 185(19): 3617-3636.e19, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070752
3.
Mapping the T cell repertoire to a complex gut bacterial community.
Nature
; 621(7977): 162-170, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587342
4.
Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.
Proc Natl Acad Sci U S A
; 120(5): e2208960120, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689660
5.
The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review.
Diabetes Obes Metab
; 26(4): 1157-1170, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225217
6.
Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 Inhibitors.
Dig Dis Sci
; 69(5): 1602-1607, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502378
7.
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.
Proc Natl Acad Sci U S A
; 118(33)2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380736
8.
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
Am J Hum Genet
; 107(5): 882-894, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022220
9.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927451
10.
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Diabetes Obes Metab
; 25(4): 965-974, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514843
11.
iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study.
Diabetes Obes Metab
; 25(1): 68-77, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123617
12.
The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury.
Int J Mol Sci
; 24(9)2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175958
13.
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists.
Stroke
; 53(5): 1813-1822, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259929
14.
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
Diabetes Obes Metab
; 24(9): 1861-1868, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589616
15.
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
Diabetes Obes Metab
; 24(12): 2391-2399, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054624
16.
Heart failure with reduced ejection fraction and the intersection of cardio-renal-metabolic medicine #CaReMe.
Eur Heart J Suppl
; 24(Suppl L): L29-L37, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545231
17.
The role of icosapent ethyl in cardiovascular risk reduction.
Curr Opin Cardiol
; 36(5): 661-671, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929367
18.
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
Diabetes Obes Metab
; 23(7): 1588-1593, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687748
19.
MoMo: discovery of statistically significant post-translational modification motifs.
Bioinformatics
; 35(16): 2774-2782, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596994
20.
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues.
Diabetes Metab Res Rev
; 36(7): e3329, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315508